The departure of Perrigo chairman and CEO Joseph Papa comes six months after the company successfully defended a $26 billion takeover bid by Mylan. With a changing of the guard…
GlaxoSmithKline’s (GKS) CEO Sir Andrew Witty has announced his intention to retire from the company in early 2017. The board will now conduct a formal search for a successor and…
Alignment of Risk and Strategy Tops Boards’ Concerns
A recent executive study puts risk management as a key component of overall corporate strategy. So where are companies focusing their attention? DCAT Value Chain Insights (VCI) takes an inside look.…
CEO Insights: What to Expect from the $160 Billion Merger of Pfizer and Allergan
At a recent investors’ conference Ian Read, chairman and CEO of Pfizer, and Brent Saudners, CEO and president of Allergan, discussed the companies’ pending $160 billion merger. DCAT Value Chain…
